Why the study?
Do elevated serum sST2 and NT-proBNP levels at presentation predict 1-year MACCE in STEMI patients undergoing primary PCI?
Population
323 consecutive patients with STEMI undergoing primary PCI, mean age 59.1±13.1 years, 84% men.
Comparison
High serum sST2 and/or high serum NT-proBNP at… vs Low serum sST2 and/or low serum NT-proBNP at…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Serum sST2 may refine post-PCI STEMI risk stratification; leaves open whether it improves outcomes over standard markers in prospective trials.
Do elevated serum sST2 and NT-proBNP levels at presentation predict 1-year MACCE in STEMI patients undergoing primary PCI?
Elevated serum sST2 and NT-proBNP at presentation independently predict 1-year MACCE in STEMI patients undergoing primary PCI, with the combination yielding the highest risk.
Yu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: